A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement and selection of attributes and levels
Patient Preference and Adherence2018Vol. Volume 12, pp. 1537–1555
Citations Over TimeTop 21% of 2018 papers
Elke Mathijssen, Milou van Heuckelum, Liset van Dijk, Marcia Vervloet, Simone Zonnenberg, Johanna E Vriezekolk, Bart J. F. van den Bemt
Abstract
This study contributes to the limited literature on the development of attributes and levels. Future research should pay more attention to a comprehensive description of this process. It ensures transparency and thereby allows researchers to judge a DCE's quality and generalizability.
Related Papers
- → A new consensus mining approach to group ranking problems involving different intensities of preferences(2019)9 cited
- → Adverse reactions and safety of newer disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis(2007)1 cited
- → Biologic treatments for rheumatoid arthritis(2019)1 cited
- Biologic agents for rheumatoid arthritis treatment(2011)
- → What is the effect of adding a disease-modifying antirheumatic drug (DMARD) to methotrexate (MTX) for people with rheumatoid arthritis and an inadequate response to MTX alone?(2020)